Captrust Financial Advisors
- SEC CIK
- 0001512024
- Latest filing
- Aug 13, 2026
VTGN holding history
Vistagen Therapeutics, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VTGN overviewAll 13F holders of VTGNFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −3,640−100.0% | Sold outConverted for a 1-for-30 split | Holders |
| Q1 2023 | 109,190 | $13.6K | <0.1% | +109,190 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −105,000−100.0% | Sold out | Holders |
| Q3 2022 | 105,000 | $16.0K | <0.1% | +100,000+2,000.0% | Added | Holders |
| Q2 2022 | 5,000 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 5,000 | $6.00K | <0.1% | −8,265−62.3% | Reduced | Holders |
| Q4 2021 | 13,265 | $26.0K | <0.1% | +7,914+147.9% | Added | Holders |
| Q3 2021 | 5,351 | $15.0K | <0.1% | +351+7.0% | Added | Holders |
| Q2 2021 | 5,000 | $16.0K | <0.1% | +5,000 | New | Holders |